Peginterferon alfa2a - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
PEGASYS peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe
AUST R: 91836
Active ingredients:
Peginterferon alfa2a

Dosage form:
Injection, solution

Sponsor:
Echo Therapeutics Pty Ltd

Phone:
1300848328

From
27 May 2025
to
15 Dec 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in consumer demand

Management action:
This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328. The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection
PEGASYS peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe
AUST R: 91837
Active ingredients:
Peginterferon alfa2a

Dosage form:
Injection, solution

Sponsor:
Echo Therapeutics Pty Ltd

Phone:
1300848328

From
13 May 2025
to
15 Dec 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in consumer demand

Management action:
This medicine can be accessed through the Pegasys Home Delivery Program. For information on this program, go to https://www.echotherapeutics.com.au/echocarepegasyspatient. An unregistered product has also been approved for supply under Section 19A. The approval holder, Echo Therapeutics Pty Ltd, can be contacted for details on supply on 1300 848 328. The TGA have published a webpage with information about these shortages: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-pegasys-peginterferon-alfa-2a-injection